Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 6Thoracic 5Head & Neck 2Tumor-Agnostic 1Genitourinary 1Dermatologic 1CNS 1Breast 1

Conditions

Glioma 1

Interventions

Magnetic Resonance Spectroscopy 52Radiosurgery 38Radiotherapy 24Blood Specimen Collection 21Magnetic Resonance Imaging 17Bevacizumab 16Temozolomide 13Radiation 12Proton Therapy 10Specimen Handling 9Radiotherapy, Intensity-Modulated 9Mental Status and Dementia Tests 9Carboplatin 9Surgical Procedures, Operative 8Exercise 8Dexmedetomidine 8Vincristine 7Surveys and Questionnaires 7Spinal Puncture 7Etoposide 7Drug Therapy 7Biopsy 7Saline Solution 6Diffusion Tensor Imaging 6Dexamethasone 6Cyclophosphamide 6Therapeutics 5Standard of Care 5Restraint, Physical 5Propofol 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Tea × CNS × Clear all
NCT01305122 2021-02-09

Tumor and Treatments Impact on Neurocognitive Functions and Quality of Life of Patients With OMS Grade II Glioma

Centre Leon Berard

Phase NA Terminated
112 enrolled
CNS

Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡